If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,255.00
Bid: 2,220.00
Ask: 2,290.00
Change: -60.00 (-2.61%)
Spread: 70.00 (3.153%)
Open: 2,295.00
High: 2,240.00
Low: 2,240.00
Prev. Close: 2,300.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Long Term Incentive Plan Awards

19 Nov 2021 14:46

RNS Number : 0153T
Craneware plc
19 November 2021
 

 

Craneware plc

("Craneware" or the "Company")

 

Grant of Long Term Incentive Plan Awards

 

19 November 2021 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 18 November 2021, under the terms of the Craneware plc Long Term Incentive Plan (2016) ("LTIP"), a conditional award of ordinary shares of 1p each in the Company ("Shares") was granted to two Directors of the Company as follows:

 

Director

No. of Shares over which a conditional share award was granted

Percentage of issued share capital

Keith Neilson (CEO)

24,896

0.07%

Craig Preston (CFO)

18,505

0.05%

 

The awards will ordinarily vest after three years subject to:

 

(i) the satisfaction of certain performance conditions based on the Company's total shareholder return ("TSR") performance relative to the performance achieved by the constituent companies within the FTSE AIM 100 Index; and

(ii) the Director's continued employment.

 

The performance conditions are measured in three tranches such that one third of the Shares over which the LTIP awards subsist will vest based on performance over the three years ending on 30 June 2022, one third based on performance over the three years ending 30 June 2023 and the final third based on performance over the three years to 30 June 2024 - an aggregate five year period. Any tranche (or part thereof) that does not meet the performance criteria will lapse.

 

If and to the extent that these LTIP awards vest, the resulting (net of tax) Shares will be subject to a two year holding period.

 

There was no consideration for the grant of the LTIP awards and no consideration will be payable by the award holders to receive the Shares from these LTIP awards, if and to the extent that they vest. 

 

 

PDMR notification: Keith Neilson

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Keith Neilson

 

2. Reason for the notification

a) Position / status CEO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 24,896, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 24,896 

ii. Price Price(s) £0

 

f) Date of the transaction 2021-11-18

 

g) Place of the transaction Outside a trading venue

 

PDMR notification: Craig Preston

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Craig Preston

 

2. Reason for the notification

a) Position / status CFO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 18,505, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 18,505

ii. Price Price(s) £0

 

f) Date of the transaction 2021-11-18

 

g) Place of the transaction Outside a trading venue

 

 

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

 

Craig Preston, CFO

 

 

 

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Hilary Buchanan, Joe Pederzolli

craneware@almapr.co.uk

 

 

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Dan Webster, George Sellar, Andrew Clark

 

 

 

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Sebastian Lawrence

 

  

 

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Jack Botros, Alix Mecklenburg-Solodkoff

 

 

 

About Craneware

 

We at the Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organizations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for U.S. healthcare providers.

 

Our combined suite of applications and industry-leading team of experts help our customers contextualize operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.

 

Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 2000 U.S hospitals and health systems and almost 10,000 clinics and retail pharmacies. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

 

Learn more at craneware.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFDFLUEFSELF
Date   Source Headline
17th Nov 20201:30 pmRNSResult of AGM
17th Nov 20207:00 amRNSAGM Statement
19th Oct 20207:00 amRNSNotice of AGM & Q1 Trading Update
15th Oct 20207:00 amRNSBlock listing Interim Review
2nd Oct 20203:55 pmRNSGrant of Long Term Incentive Plan Awards
21st Sep 20207:00 amRNSFinal Results
18th Aug 20207:00 amRNSPurchase of Shares and Exercise of Share Options
12th Aug 20207:00 amRNSUpdate on Proposed Placing
11th Aug 20205:00 pmRNSProposed Accelerated Bookbuild
8th Jul 20207:00 amRNSTrading Update
18th Jun 20202:37 pmRNSHolding(s) in Company
21st Apr 20205:04 pmRNSGrant of Share Options
20th Apr 202011:05 amRNSSecond Price Monitoring Extn
20th Apr 202011:00 amRNSPrice Monitoring Extension
15th Apr 20205:15 pmRNSBlock listing Interim Review
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
26th Mar 20204:31 pmRNSVesting of Long Term Incentive Plan Award
20th Mar 20202:02 pmRNSDividend Currency Election
20th Mar 20209:00 amRNSBlocklisting Application
3rd Mar 20207:00 amRNSHalf-year Report
24th Feb 20207:00 amRNSBoard Appointments
23rd Jan 20202:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20202:00 pmRNSPrice Monitoring Extension
23rd Jan 20207:00 amRNSTrading Update and Notice of Results
23rd Dec 20193:15 pmRNSDirector/PDMR Shareholding and Total Voting Rights
20th Dec 201912:10 pmRNSHolding(s) in Company
29th Nov 201912:29 pmRNSDividend Currency Election
25th Nov 20195:23 pmRNSHolding(s) in Company
22nd Nov 201911:01 amRNSTotal Voting Rights
18th Nov 20197:00 amRNSShare Purchase by Chairman Designate
13th Nov 20194:10 pmRNSResult of AGM
12th Nov 20197:00 amRNSAGM Statement
16th Oct 201910:46 amRNSBlock listing Interim Review
11th Oct 20194:17 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20194:41 pmRNSSecond Price Monitoring Extn
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
18th Sep 20197:00 amRNSDirector/PDMR Shareholding
16th Sep 201912:03 pmRNSHolding(s) in Company
4th Sep 20196:14 pmRNSGrant of Long Term Incentive Plan Awards
3rd Sep 20197:00 amRNSFinal Results
2nd Sep 201911:23 amRNSBlocklisting Application
1st Jul 20192:00 pmRNSPrice Monitoring Extension
28th Jun 20199:05 amRNSSecond Price Monitoring Extn
28th Jun 20199:00 amRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSTrading Update and Notice of Results
15th Apr 20197:00 amRNSBlock listing Interim Review
15th Mar 20192:50 pmRNSDividend Currency Election
5th Mar 20197:00 amRNSHalf-year Report
21st Dec 20187:00 amRNSTrading Update and Notice of Results
15th Nov 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.